Immunogenicity for Biopharmaceuticals & Biosimilars Asia 2012
Predicting and Mitigating the Risk of Unwanted Immunogenicity
15 - 17 Oct 2012, Singapore
Dear Professional
Informa Life Sciences has over a decade-long experience in hosting Immunogenicity conferences in the US and Europe and is pleased to present the inaugural Immunogenicity for Biopharmaceuticals & Biosimilars Asia 2012. The ONLY event of its kind in the region, researched with and designed for the community of scientists driving progress and innovation in immunogenicity studies in the region. Bringing you global best practices and case studies, teamed with emerging local knowledge, this event will assist you in formulating solutions to your top immunogenicity challenges.
Given the rapid growth of the biopharmaceutical and biosimilar industry in Asia, success in the design and commercialization of your product will depend on your capacity to predict and mitigate the risk of unwanted immunogenicity. Don't miss critical regulatory updates, international industry best practice and current regional developments at Immunogenicity for Biopharmaceuticals & Biosimilars Asia.
Why Attend Immunogenicity Asia?
· Learn from and network with leading international and regional immunology and bioanalytical scientists
· New Perspectives! Discuss regional differences in immunogenic response between Asian and Caucasian populations and their implications in drug development
· Gain an understanding of critical immunogenicity factors to consider in Biosimilars development and the impact on product development and regulatory approval
· Discuss the latest models for predicting and assessing immunogenicity risk, including in-silico, in-vitro and in-vivo approaches
· Gain current perspectives on preparing and validating assays
For more information,
Call: + 65 6508 2401
Email: register@ibcasia.com.sg
Web: www.immunogenicityasia.com
